Welcome Message from
John Cummins, President & CEO
|
|
|
|
Welcome to the first issue of NEXA | EAM’s newsletter - NEXA | NEWS. Our goal is to keep you updated with industry trends, case studies, and stories of personal and professional successes.
|
|
We have had a whirlwind of a year in 2021 so far – with new clients, new colleagues, new projects, new services, and even a new name, as NEXA | EAM replaced CalOpEx. We also celebrated 6 years in business in June. I am beyond proud that what began as a single person operation in 2015, has now grown to more than 50 active projects and a growing team across the U.S. and Ireland.
Most excitingly, we are currently in the process of executing multiple Exploratory Phase Evaluations (EPEs) with client sites in the U.S., mainland Europe, Asia, South America, and Africa. We have delivered real value to our clients through our customized EPEs and the subsequent optimization projects. As of the end of 2020 have achieved over $5M in annual recurring savings for our clients.
|
|
I hope you find value from our first issue. And in the spirit of continuous improvement, we welcome suggestions and feedback, so please, let us know what you think and also what topics you like to see covered in the next issue!
In the meantime, I invite you to contact me directly via the link below to learn more about the NEXA | EPE and other service offerings, and we can start a conversation.
|
|
5 Steps to Lowering Mean Time to Repair (MTTR): How Spare Parts Influence Overall Equipment Availability
|
In the life sciences industry, operations and maintenance professionals understand critical equipment failure is inevitable. Risks may include significant downtime and scheduling bottlenecks for production, introduced stress for engineering and repair crews, and reduced effectivness in metrics such as Planned Production Time and Overall Equipment Availability (OEA). At NEXA, we have noted that a higher than acceptable exposure to workflow slowdowns stem from a simple lack of spare parts, identified at the critical juncture, and often too late. However, this risk can be mitigated beginning with the most high-volume cross department use areas, by drilling down on what may appear to be low ROI work and solving the problem.
Many large pharmaceutical companies worldwide have faced these issues—however, it does not need to be an acceptable cost of doing business, particularly for an industry that is providing life-saving and life-enhancing products. If companies recognize and work to resolve Mean Time To Repair (MTTR), using a targeted Spare Parts Program Review (SPPR), they can improve efficiency and implement a high-quality process to ensure production remains on track, and schedules intact.
|
|
Taking Corrective Actions
A process to reduce MTTR can be achieved in the following five steps:
1) Reporting the Issue Effectively
2) Planning the Repair
3) Scheduling the Resources
4) Troubleshooting Underlying Issues
5) Installing the Correct Part
|
|
Creating Value | Exploratory Phase Evaluation (EPE) |
|
|
NEXA | EAM offers 5 Service Tracks that will support the creation or optimization of your Enterprise Asset Management Program (EAM). Whether your facility is in the preconstruction, operational or decommissioning stage—our experienced team can deliver results in all phases of the Asset Lifecycle.
The NEXA | EPE service, however, is often the first step for most clients who are looking to identify areas for improvement. The EPE was designed specifically for the Life Sciences industry, and is a unique service will assess your program’s current state of operation and provide you with concrete data you need to make sound decisions and provide evidence of ROI to secure funding.
How it works: The NEXA | EAM team takes a deep dive into the inner workings of your Asset Management Program to find ways to optimize performance, reduce annual spend, and improve quality. From information gathered and analyzed, we will customize an EPE report, which provides the justification needed for securing the resources and funding to transform your EAM Program. We guarantee 15% Annual Savings in your asset management program or your EPE is free of charge.
Are you ready to improve your current Asset Management Program? Contact us to learn more at nexaeam.com/connect.
|
|
|
 |
|
|
|
5 Considerations for any Life Sciences company striving to improve their Asset Management Program!
|
1 | Data is King! Bad Data = Bad Asset Management!
2 | Paper Produces Problems. Digital Asset Management is the only way!
3 | Prevention is better than the cure. Prediction is better than both!
4 | Unplanned downtime = Unplanned Production Shortages!
5 | If everything is Critical...Nothing is Critical!
|
|
|
|
Delivering Results | Project Spotlight |
|
|
|
|
Client Case Study: EPE Services | U.S.
|
About Our Client
Our client site, one of the largest sterile injectable facilities in the world, produces almost 25% of all sterile injectables used in U.S. hospitals. Annually, the site produces more than 400 million units for patients in the U.S. and around the world.
Business Challenge: Why Client opted for the NEXA | EPE
With such a high volume of output from the site, equipment uptime and availability is essential. Although different continuous improvement efforts were underway in the areas of Maintenance, Calibration, Reliability and Spares Management, there was no overarching report on the current state, the proposed future state, and the amount of value obtainable from these different efforts. The site considered the EPE the best way to capture all of this information in the shortest amount of time.
Our EPE Approach
Two NEXA | EAM specialists spent a week at the facility holding interviews and reviewing data with experts from all of the various engineering functions. Our ability to quickly understand and analyze the information based on all of our previous experiences meant we could deliver a comprehensive report by the end of the week that outlined the key findings we had observed.
Click here to read about Our Findings, Recommendations and Benefits of the NEXA | EPE.
|
|
|
|
|
|
|
|
